Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 214

1.

Is Resveratrol likely to be an effective agent in therapeutic intervention for Alzheimer's disease?

Braidy N, Jugder BE, Poljak A, Jayasena T, Mansour H, Nabavi SM, Sachdev P, Grant R.

Curr Top Med Chem. 2016 Feb 4. [Epub ahead of print]

PMID:
26845555
2.

Neuroprotective role of natural polyphenols.

Spagnuolo C, Napolitano M, Tedesco I, Moccia S, Milito A, Russo GL.

Curr Top Med Chem. 2016 Feb 4. [Epub ahead of print]

PMID:
26845551
3.

Pharmacological activities and structure-modification of resveratrol analogues.

Xiao Y, Chen H, Song C, Zeng X, Zheng Q, Zhang Y, Lei X, Zheng X.

Pharmazie. 2015 Dec;70(12):765-71.

PMID:
26817272
4.

Alzheimer's disease: An overview of amyloid beta dependent pathogenesis and its therapeutic implications along with in silico approaches emphasizing the role of natural products.

Awasthi M, Singh S, Pandey VP, Dwivedi UN.

J Neurol Sci. 2016 Feb 15;361:256-71. doi: 10.1016/j.jns.2016.01.008. Epub 2016 Jan 8. Review.

PMID:
26810552
5.

Chronic administration of resveratrol prevents morphological changes in prefrontal cortex and hippocampus of aged rats.

Hernández-Hernández EM, Serrano-García C, Vázquez-Roque RA, Díaz A, Monroy E, Rodríguez-Moreno A, Florán B, Flores G.

Synapse. 2016 Jan 20. doi: 10.1002/syn.21888. [Epub ahead of print]

PMID:
26789275
6.

Metal chelation, radical scavenging and inhibition of Aβ42 fibrillation by food constituents in relation to Alzheimer's disease.

Chan S, Kantham S, Rao VM, Palanivelu MK, Pham HL, Shaw PN, McGeary RP, Ross BP.

Food Chem. 2016 May 15;199:185-94. doi: 10.1016/j.foodchem.2015.11.118. Epub 2015 Nov 26.

PMID:
26775960
7.

Brain-inspired cheminformatics of drug-target brain interactome, synthesis, and assay of TVP1022 derivatives.

Romero-Durán FJ, Alonso N, Yañez M, Caamaño O, García-Mera X, González-Díaz H.

Neuropharmacology. 2015 Dec 23;103:270-278. doi: 10.1016/j.neuropharm.2015.12.019. [Epub ahead of print]

PMID:
26721628
8.

Beneficial action of resveratrol: How and why?

Diaz-Gerevini GT, Repossi G, Dain A, Tarres MC, Das UN, Eynard AR.

Nutrition. 2016 Feb;32(2):174-8. doi: 10.1016/j.nut.2015.08.017. Epub 2015 Sep 25. Review.

PMID:
26706021
9.

Novel Therapeutic Targets and Drug Candidates for Modifying Disease Progression in Adrenoleukodystrophy.

Pujol A.

Endocr Dev. 2016;30:147-60. doi: 10.1159/000439340. Epub 2015 Dec 10.

PMID:
26684655
10.

Attenuation of Oxidative Stress in HEK 293 Cells by the TCM Constituents Schisanhenol, Baicalein, Resveratrol or Crocetin and Two Defined Mixtures.

Bend JR, Xue Yan Xia XY, Chen D, Awaysheh A, Lo A, Rieder MJ, Rylett RJ.

J Pharm Pharm Sci. 2015 Nov;18(4):661-82.

11.

Novel promising therapeutics against chronic neuroinflammation and neurodegeneration in Alzheimer's disease.

Venigalla M, Sonego S, Gyengesi E, Sharman MJ, Münch G.

Neurochem Int. 2015 Oct 31. pii: S0197-0186(15)30061-9. doi: 10.1016/j.neuint.2015.10.011. [Epub ahead of print] Review.

PMID:
26529297
12.

Resveratrol Reverses the Synaptic Plasticity Deficits in a Chronic Cerebral Hypoperfusion Rat Model.

Li H, Wang J, Wang P, Rao Y, Chen L.

J Stroke Cerebrovasc Dis. 2016 Jan;25(1):122-8. doi: 10.1016/j.jstrokecerebrovasdis.2015.09.004. Epub 2015 Oct 9.

PMID:
26456198
13.

[Effects of resveratrol on hippocampal astrocytes and expression of TNF-α in Alzheimer's disease model rate].

Cheng X, Wang Q, Li N, Zhao H.

Wei Sheng Yan Jiu. 2015 Jul;44(4):610-4. Chinese.

PMID:
26454959
14.

Resveratrol decreases the insoluble Aβ1-42 level in hippocampus and protects the integrity of the blood-brain barrier in AD rats.

Zhao HF, Li N, Wang Q, Cheng XJ, Li XM, Liu TT.

Neuroscience. 2015 Dec 3;310:641-9. doi: 10.1016/j.neuroscience.2015.10.006. Epub 2015 Oct 11.

PMID:
26454022
15.

A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease.

Turner RS, Thomas RG, Craft S, van Dyck CH, Mintzer J, Reynolds BA, Brewer JB, Rissman RA, Raman R, Aisen PS; Alzheimer's Disease Cooperative Study.

Neurology. 2015 Oct 20;85(16):1383-91. doi: 10.1212/WNL.0000000000002035. Epub 2015 Sep 11.

16.

The Molecular Mechanism of Amyloid β42 Peptide Toxicity: The Role of Sphingosine Kinase-1 and Mitochondrial Sirtuins.

Cieślik M, Czapski GA, Strosznajder JB.

PLoS One. 2015 Sep 3;10(9):e0137193. doi: 10.1371/journal.pone.0137193. eCollection 2015.

17.

Resveratrol inhibits oligomeric Aβ-induced microglial activation via NADPH oxidase.

Yao Y, Li J, Niu Y, Yu JQ, Yan L, Miao ZH, Zhao XX, Li YJ, Yao WX, Zheng P, Li WQ.

Mol Med Rep. 2015 Oct;12(4):6133-9. doi: 10.3892/mmr.2015.4199. Epub 2015 Aug 7.

PMID:
26252250
18.

Cilostazol Upregulates Autophagy via SIRT1 Activation: Reducing Amyloid-β Peptide and APP-CTFβ Levels in Neuronal Cells.

Lee HR, Shin HK, Park SY, Kim HY, Bae SS, Lee WS, Rhim BY, Hong KW, Kim CD.

PLoS One. 2015 Aug 5;10(8):e0134486. doi: 10.1371/journal.pone.0134486. eCollection 2015.

19.

An Organ System Approach to Explore the Antioxidative, Anti-Inflammatory, and Cytoprotective Actions of Resveratrol.

Malhotra A, Bath S, Elbarbry F.

Oxid Med Cell Longev. 2015;2015:803971. doi: 10.1155/2015/803971. Epub 2015 Jun 9. Review.

20.

Resveratrol: A Focus on Several Neurodegenerative Diseases.

Tellone E, Galtieri A, Russo A, Giardina B, Ficarra S.

Oxid Med Cell Longev. 2015;2015:392169. doi: 10.1155/2015/392169. Epub 2015 Jun 9. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk